Eiger Biopharmaceuticals (EIGRQ)
OTHER OTC:EIGRQ
US Market

Eiger Biopharmaceuticals (EIGRQ) Ownership - Who Owns Eiger Biopharmaceuticals?

595 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 02, 2023
Richard Kayne
>10% Owner
xxxxxxxxxxxxx
$71434
Nov 02, 2023
Leen Kawas
>10% Owner
xxxxxxxxxxxxx
$6326

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,843,170Insider192.00%38,382,795
384,555Institution25.97%5,191,493
150,034Institution10.13%2,025,459
145,303Institution9.81%1,961,591
112,637Institution7.61%1,520,599
102,800Institution6.94%1,387,800
96,953Institution6.55%1,308,866
90,000Institution6.08%1,215,000
69,890Institution4.72%943,515
62,500Insider4.22%843,750

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
384,555Institution25.97%5,191,493
150,034Institution10.13%2,025,459
145,303Institution9.81%1,961,591
112,637Institution7.61%1,520,599
102,800Institution6.94%1,387,800
96,953Institution6.55%1,308,866
69,890Institution4.72%943,515
58,377Institution3.94%788,090
33,367Institution2.25%450,455
27,682Institution1.87%373,707

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
90,000Institution6.08%1,215,000

FAQ

Who Owns Eiger Biopharmaceuticals (EIGRQ)?
Currently, no data Available
What percentage of Eiger Biopharmaceuticals (EIGRQ) stock is held by institutional investors?
Currently, no data Available
What percentage of Eiger Biopharmaceuticals (EIGRQ) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Eiger Biopharmaceuticals (EIGRQ)?
Ecor1 Capital, Llc owns the most shares of Eiger Biopharmaceuticals (EIGRQ).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis